- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
CDSCO issues Cancelled permission List manufacturers
New Delhi: The Central Drugs Standard Control Organization (CDSCO) has published a list of the details of manufacturers whose permissions have been suspended or canceled for specific products.
The list of products includes Sanofi Healthcare's Diphtheria,Tetanus, Whole Cell Pertussis, Hepatitis B and Haemophilus influenzae Type b (PRP-T)Conjugate vaccine (adsorbed) (Abbreviated as DTwPHepB-Hib vaccine) in liquid vaccine form; Diphtheria + Tetanus + Pertussis + Hepatitis B (rDNA) + Haemophilus influenzae Type b (TT Conjugate) Vaccine; Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate vaccine (Adsorbed); Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) vaccine (Adsorbed).
Details of Manufacturers whose permissions have been suspended/cancelled 2024
Sr. No. | Name & address of Manufacturer | Name of product | Permission No | Action taken (Suspended /Cancelled) | Date of Suspension/ Cancellation | Period of Suspension/ Cancellation |
1 | M/s Sanofi Healthcare India Private Limited, Survey No. 274, Athvelli Village, Medchal Mandal- 501401, Medchal- Malkajgiri District, Telangana, India | Diphtheria,Tetanus, Whole Cell Pertussis, Hepatitis B and Haemophilus influenzae Type b (PRP-T)Conjugate vaccine (adsorbed) (Abbreviated as DTwP- HepB-Hib vaccine) in liquid vaccine form | MF-55/2014, Dated 07 Mar 2014 | Cancelled | 10-07-2024 | Permanent |
2 | M/s Sanofi Healthcare India Private Limited, Survey No. 274, Athvelli Village, Medchal Mandal- 501401, Medchal- Malkajgiri District, Telangana, India | Diphtheria + Tetanus + Pertussis + Hepatitis B (rDNA) + Haemophilus influenzae Type b (TT Conjugate) Vaccine | MF-7225/07, Dated 23 Feb 2007 | Cancelled | 10-07-2024 | Permanent |
3 | M/s Sanofi Healthcare India Private Limited, Survey No. 274, Athvelli Village, Medchal Mandal- 501401, Medchal- Malkajgiri District, Telangana, India | Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate vaccine (Adsorbed) I. P. | MF/BIO/21/000116, Dated 26 Oct 2021 | Cancelled | 10-07-2024 | Permanent |
4 | M/s Sanofi Healthcare India Private Limited, Survey no. 354, Muppireddipalli village, Manoharabad mandal-502236 | Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate vaccine (Adsorbed) I.P. | MF/BIO/21/000109, Dated 29- Sep-2021 | Cancelled | 10-07-2024 | Permanent |
5 | M/s Sanofi Healthcare India Private Limited, Survey no. 354, Muppireddipalli village, Manoharabad mandal-502236 | Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA),Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) vaccine (Adsorbed) | MF/BIO/21/000047 dated 25-May-2021 | Cancelled | 10-07-2024 | Permanent |
6 | M/s Sanofi Healthcare India Private Limited, Survey No. 274, Athvelli Village, Medchal Mandal- 501401, Medchal- Malkajgiri District, Telangana, India | Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), Haemophilus influenzae Type b Conjugate and Poliomyelitis (Inactivated) vaccine (Adsorbed) | MF/BIO/21/000044, dated 12-May-2021 | Cancelled | 10-07-2024 | Permanent |
To view the official notice click the link below:
Mpharm (Pharmacology)
Susmita Roy, B pharm, M pharm Pharmacology, graduated from Gurunanak Institute of Pharmaceutical Science and Technology with a bachelor's degree in Pharmacy. She is currently working as an assistant professor at Haldia Institute of Pharmacy in West Bengal. She has been part of Medical Dialogues since March 2021.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751